CPIX Relative Valuation
CPIX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CPIX is overvalued; if below, it's undervalued.
Historical Valuation
Cumberland Pharmaceuticals Inc (CPIX) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 9.21. The fair price of Cumberland Pharmaceuticals Inc (CPIX) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：2.26
Fair
0.00
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
Cumberland Pharmaceuticals Inc. (CPIX) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 7.24. The thresholds are as follows: Strongly Undervalued below -20.42, Undervalued between -20.42 and -6.59, Fairly Valued between 21.08 and -6.59, Overvalued between 21.08 and 34.91, and Strongly Overvalued above 34.91. The current Forward EV/EBITDA of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.99
EV/EBIT
Cumberland Pharmaceuticals Inc. (CPIX) has a current EV/EBIT of 0.99. The 5-year average EV/EBIT is -3.14. The thresholds are as follows: Strongly Undervalued below -13.77, Undervalued between -13.77 and -8.45, Fairly Valued between 2.18 and -8.45, Overvalued between 2.18 and 7.50, and Strongly Overvalued above 7.50. The current Forward EV/EBIT of 0.99 falls within the Historic Trend Line -Fairly Valued range.
0.00
PS
Cumberland Pharmaceuticals Inc. (CPIX) has a current PS of 0.00. The 5-year average PS is 0.41. The thresholds are as follows: Strongly Undervalued below -0.61, Undervalued between -0.61 and -0.10, Fairly Valued between 0.92 and -0.10, Overvalued between 0.92 and 1.43, and Strongly Overvalued above 1.43. The current Forward PS of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
Cumberland Pharmaceuticals Inc. (CPIX) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.
26.23
P/FCF
Cumberland Pharmaceuticals Inc. (CPIX) has a current P/FCF of 26.23. The 5-year average P/FCF is 34.31. The thresholds are as follows: Strongly Undervalued below -67.83, Undervalued between -67.83 and -16.76, Fairly Valued between 85.38 and -16.76, Overvalued between 85.38 and 136.45, and Strongly Overvalued above 136.45. The current Forward P/FCF of 26.23 falls within the Historic Trend Line -Fairly Valued range.
Cumberland Pharmaceuticals Inc (CPIX) has a current Price-to-Book (P/B) ratio of 1.31. Compared to its 3-year average P/B ratio of 1.20 , the current P/B ratio is approximately 8.93% higher. Relative to its 5-year average P/B ratio of 1.11, the current P/B ratio is about 18.07% higher. Cumberland Pharmaceuticals Inc (CPIX) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 16.18%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 14.86% , the current FCF yield is about -100.00% lower.
1.35
P/B
Median3y
1.20
Median5y
1.11
19.75
FCF Yield
Median3y
16.18
Median5y
14.86
Competitors Valuation Multiple
The average P/S ratio for CPIX's competitors is 0.74, providing a benchmark for relative valuation. Cumberland Pharmaceuticals Inc Corp (CPIX) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of -8.73%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of CPIX decreased by 0.84% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -16.92 to -23.50.
The secondary factor is the Revenue Growth, contributed -8.73%to the performance.
Overall, the performance of CPIX in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
FAQ
Is Cumberland Pharmaceuticals Inc (CPIX) currently overvalued or undervalued?
What is Cumberland Pharmaceuticals Inc (CPIX) fair value?
How does CPIX's valuation metrics compare to the industry average?
What is the current P/B ratio for Cumberland Pharmaceuticals Inc (CPIX) as of Dec 05 2025?
What is the current FCF Yield for Cumberland Pharmaceuticals Inc (CPIX) as of Dec 05 2025?
What is the current Forward P/E ratio for Cumberland Pharmaceuticals Inc (CPIX) as of Dec 05 2025?